These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 39248472)

  • 1. Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens.
    Plumet L; Costechareyre D; Lavigne J-P; Kissa K; Molle V
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0082924. PubMed ID: 39248472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage therapy: an alternative treatment modality for MDR bacterial infections.
    Pal N; Sharma P; Kumawat M; Singh S; Verma V; Tiwari RR; Sarma DK; Nagpal R; Kumar M
    Infect Dis (Lond); 2024 Oct; 56(10):785-817. PubMed ID: 39017931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance: use of phage therapy in the management of resistant infections.
    Ikpe F; Williams T; Orok E; Ikpe A
    Mol Biol Rep; 2024 Aug; 51(1):925. PubMed ID: 39167154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
    Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
    Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The zebrafish embryo model: unveiling its potential for investigating phage therapy against methicillin-resistant
    Plumet L; Magnan C; Ahmad-Mansour N; Sotto A; Lavigne J-P; Costechareyre D; Kissa K; Molle V
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0056124. PubMed ID: 38899926
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic
    Zhao M; Li H; Gan D; Wang M; Deng H; Yang QE
    mSystems; 2024 Sep; 9(9):e0060724. PubMed ID: 39166877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage Therapy: An Alternative Approach to Combating Multidrug-Resistant Bacterial Infections in Cystic Fibrosis.
    Cocorullo M; Stelitano G; Chiarelli LR
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125890
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Li S; Wei B; Xu L; Cong C; Murtaza B; Wang L; Li X; Li J; Xu M; Yin J; Xu Y
    J Virol; 2024 Jul; 98(7):e0046724. PubMed ID: 38864621
    [No Abstract]   [Full Text] [Related]  

  • 11. [System analysis of the ecological distribution of bacteriophages in hospital wastewater].
    Lu JY; Pan HW; Sun EH; Li W; Wang HX; Zhao XL; Wang HC
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):241-247. PubMed ID: 38387957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted phage hunting to specific
    Ferriol-González C; Concha-Eloko R; Bernabéu-Gimeno M; Fernández-Cuenca F; Cañada-García JE; García-Cobos S; Sanjuán R; Domingo-Calap P
    Microbiol Spectr; 2024 Oct; 12(10):e0025424. PubMed ID: 39194291
    [No Abstract]   [Full Text] [Related]  

  • 13. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
    Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens.
    Al-Ishaq RK; Skariah S; Büsselberg D
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33396965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage treatment as an alternative therapy for multidrug-resistant bacteria.
    Alqahtani A
    Saudi Med J; 2023 Dec; 44(12):1222-1231. PubMed ID: 38016738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.